P

Inventor

HONKANEN ERKKI J

FI16 patents
⚠️ This page may combine multiple inventors who share the name “HONKANEN ERKKI J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ORION YHTYMAE OY

15 patents
US5446194AAug 29, 1995

Pharmacologically active catechol derivatives

ORION YHTYMAE OY108 citations96
US4963590AOct 16, 1990

Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same

ORION YHTYMAE OY156 citations96
US5283352AFeb 1, 1994

Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same

ORION YHTYMAE OY60 citations94
US5135950AAug 4, 1992

Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation

ORION YHTYMAE OY72 citations92
US5112861AMay 12, 1992

Method of treating parkinson's disease using pentanedione derivatives

ORION YHTYMAE OY48 citations91
US4599326AJul 8, 1986

Acetyl erythromycin stearate, and compositions containing it

ORION YHTYMAE OY29 citations87
US5288750AFeb 22, 1994

Substituted β-diketones

ORION YHTYMAE OY8 citations72
US4299846ANov 10, 1981

Dihydroxy-acylanthrones having anti-psoriatic activity

ORION YHTYMAE OY13 citations71
US5292771AMar 8, 1994

Substituted β-diketones and their use

ORION YHTYMAE OY12 citations70
US5185370AFeb 9, 1993

Substituted β-diketones and their use

ORION YHTYMAE OY10 citations70
US5512572AApr 30, 1996

Anti-ischemic medicament

ORION YHTYMAE OY12 citations67
US5001152AMar 19, 1991

Use of catechol-O-methyl transferase (COMT) inhibitors and their physiologically acceptable salts for ulcer treatment

ORION YHTYMAE OY3 citations58
US4271300AJun 2, 1981

Method for producing 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl] qu

ORION YHTYMAE OY5 citations56
US4963677AOct 16, 1990

Heterocyclic lactam compounds

ORION YHTYMAE OY5 citations55
US4353914AOct 12, 1982

Antitussive anilides

ORION YHTYMAE OY5 citations50

ORION CORP ORION PHARMACEUTICA

1 patent